Moyamoya disease: a review of histopathology, biochemistry, and genetics
Authors:
- Omar M. ArnaoutOAOmar M. Arnaout
- Rudy J. RahmeRRRudy J. Rahme
- Salah G. AounSASalah G. Aoun
- H. Hunt BatjerHBH. Hunt Batjer
- Bernard R. BendokBBBernard R. Bendok
- 1 June 2011
- journal article
- review article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Neurosurgical Focus
- Vol. 30 (6) , E20
Abstract
Object: Moyamoya disease (MMD) is a rare cerebrovascular disorder involving stenosis of the major vessels of the circle of Willis and proximal portions of its principal branches. Despite concerted investigation, the pathophysiology of the disorder has not been fully elucidated. Currently, the major proteins believed to play an active role in the pathogenesis include vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), hepatocyte growth factor (HGF), transforming growth factor–β 1 (TGFβ 1 ), and granulocyte colony-stimulating factor (G-CSF). In terms of the genetics, recent literature suggests a low penetrance autosomal dominant or polygenic mode of transmission involving chromosomes 3, 6, 8, 12, and 17 for familial MMD. This review summarizes the current knowledge on the histopathology, pathophysiology and genetics of MMD. Methods: A PubMed/Medline systematic study of the literature was performed, from which 45 articles regarding MMD pathophysiology were identified and analyzed. Conclusions: Moyamoya disease is characterized by the intimal thickening and media attenuation of the proximal vessels of the circle of Willis as well as the development of an aberrant distal vascular network. The primary proteins that are currently implicated in the pathophysiology of MMD include VEGF, bFGF, HGF, TGFβ 1 , and G-CSF. Furthermore, the current literature on familial MMD has pointed to a low penetrance autosomal dominant or polygenic mode of transmittance at loci on chromosomes 3, 6, 8, 12, and 17.Keywords
This publication has 42 references indexed in Scilit:
- A novel susceptibility locus for moyamoya disease on chromosome 8q23Journal of Human Genetics, 2004
- Elevation of CRABP-I in the Cerebrospinal Fluid of Patients With Moyamoya DiseaseStroke, 2003
- Levels of Soluble Adhesion Molecules Are Elevated in the Cerebrospinal Fluid of Children with Moyamoya SyndromeNeurosurgery, 2002
- Prothrombotic Disorders in Children With Moyamoya SyndromeStroke, 2001
- Moyamoya diseaseNeuropathology, 2000
- Angiogenic Factors in Moyamoya DiseaseStroke, 1996
- Basic fibroblast growth factor in human saliva: Detection and physiological implicationsThe Laryngoscope, 1995
- Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease.Stroke, 1993
- Structure-function relationship of basic fibroblast growth factor: Site-directed mutagenesis of a putative heparin-binding and receptor-binding regionBiochemical and Biophysical Research Communications, 1992
- Cervico-cephalic arterial thrombi and thromboemboli in moyamoya disease--possible correlation with progressive intimal thickening in the intracranial major arteries.Stroke, 1984